Clin2
NCT05269459Possibly a fitRecruiting

Cannabidiol (CBD) for PTSD symptoms in adults

PTSD

Part of Mental health clinical trials.

This study tests whether CBD, a non-psychoactive compound from cannabis, can help reduce symptoms of post-traumatic stress disorder (PTSD) in adults. If you have PTSD and are interested in a non-traditional treatment option, this might be worth exploring.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
140 people
Ages
21 years to 65 years
Study type
Interventional

Who can take part

  • You are between 21 and 65 years old.
  • You have a current PTSD diagnosis (symptoms for at least a month).
  • You use marijuana (THC) no more than 3 days a week currently.
  • You are not currently using any CBD products (including Epidiolex).
  • You have been on stable mental health medications or therapy for at least 4 weeks before starting.
  • You are not pregnant, breastfeeding, or planning to become pregnant during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06222268Not yet recruiting· Phase 1/Phase 2
Cannabis plus standard therapy for veterans with PTSD

This study tests whether adding a cannabis-based treatment to standard trauma therapy helps veterans with PTSD. It aims to see if cannabis can improve the effects of that therapy.

Detroit, Michigan
NCT04452500Recruiting· Phase 2
Study drug for PTSD symptoms in Veterans

This trial tests a study medicine that blocks the effects of cortisol (a stress hormone) to reduce PTSD symptoms in Veterans. It’s meant for people with ongoing PTSD symptoms and stable treatments, and it closely checks safety because the medicine can affect sleep, mood, and heart rhythm.

Tuscaloosa, Alabama
NCT07704762Not yet recruiting· Phase 2
MDMA-assisted therapy for PTSD in U.S. service members

This study tests whether MDMA (a drug that can help people feel safe and open during therapy) combined with talk therapy can reduce PTSD symptoms in active-duty service members, National Guard, and Reserve members. If you are struggling with PTSD that has lasted at least 6 months, this trial may offer a new treatment option.

NCT04550377Recruiting· Phase 2
Cannabidiol for PTSD, including PTSD after mild head injury

This Phase 2 study tests whether cannabidiol (CBD) can reduce PTSD symptoms, including in people who also had a mild traumatic brain injury (TBI). It’s meant to see if CBD is helpful and safe for PTSD symptoms over the study period.

New York, New York
NCT06381180Recruiting· Phase 1/Phase 2
Cannabis for Veterans with PTSD

This study is testing whether cannabis can help veterans with PTSD feel better. It is for veterans who have used cannabis before and currently have PTSD symptoms.

Detroit, Michigan
NCT07224698Not yet recruiting· Phase 2
Inhaled cannabis for treating PTSD in veterans

This study tests whether inhaling cannabis can help reduce PTSD symptoms in veterans. You will receive cannabis provided by the study team and have regular check-ins to see how it affects your symptoms.

Hear when a new PTSD trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.